Financhill
Sell
29

MIRM Quote, Financials, Valuation and Earnings

Last price:
$38.60
Seasonality move :
11.84%
Day range:
$38.24 - $40.32
52-week range:
$23.14 - $54.23
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.98x
P/B ratio:
8.39x
Volume:
335.9K
Avg. volume:
495.3K
1-year change:
61.56%
Market cap:
$1.9B
Revenue:
$336.9M
EPS (TTM):
-$1.85

Earnings Data

Next earnings date for MIRM
May 08
2025
Most recent earnings per share
-$0.49
Missed by $0.25
(Feb 26/2025)
Consensus Estimate
-$0.25
(Feb 26/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MIRM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $103.6M -- -- -$0.23 --
05/08/2025 Q1 $98.4M -- -- -$0.27 --
02/26/2025 Q4 $96.6M $99.4M -$0.49 -$0.25 -$0.25
11/12/2024 Q3 $82M $90.4M -$0.30 -$0.45 $0.15
08/07/2024 Q2 $75.1M $77.9M -$0.52 -$0.46 -$0.06
05/08/2024 Q1 $70.2M $69.2M -$0.54 -$0.30 -$0.24
02/28/2024 Q4 $67.9M $69.6M -$0.71 -$0.22 -$0.48
11/02/2023 Q3 -- -- -$0.57 -$0.81 $0.24
08/03/2023 Q2 -- -- -$1.94 -$0.79 -$1.15
05/04/2023 Q1 -- -- -$0.80 -$0.97 $0.17
03/08/2023 Q4 -- -- -$0.99 -$0.92 -$0.06
11/09/2022 Q3 -- -- -$1.02 -$1.09 $0.07
08/04/2022 Q2 -- -- -$0.84 -$1.06 $0.22
05/05/2022 Q1 -- -- -$1.17 -$1.38 $0.21
03/09/2022 Q4 -- -- $1.88 $1.84 $0.04
11/15/2021 Q3 -- -- -$1.55 -$1.50 -$0.05
08/05/2021 Q2 -- -- -$1.45 -$1.08 -$0.37
05/06/2021 Q1 -- -- -$1.68 -$0.99 -$0.70
03/09/2021 Q4 -- -- -$1.43 -$0.98 -$0.45
11/12/2020 Q3 -- -- -$0.86 -$0.98 $0.12
08/06/2020 Q2 -- -- -$0.93 -$0.87 -$0.06
05/07/2020 Q1 -- -- -$0.86 -$0.84 -$0.02
03/12/2020 Q4 -- -- -$0.79 -$0.85 $0.06
11/06/2019 Q3 -- -- -$0.84 -$0.63 -$0.21
08/28/2019 Q2 -- -- -$0.59 -$0.59 $0.00

Mirum Pharmaceuticals Earnings Questions

  • How Much did Mirum Pharmaceuticals Generate in Revenue Last Quarter?

    Mirum Pharmaceuticals reported $99.4M worth of top line sales in its most recent quarter.

  • Did Mirum Pharmaceuticals Beat Earnings Last Quarter?

    Mirum Pharmaceuticals announced earnings per share of -$0.49 which represents a miss of analyst forecast a -$0.25 per share.

  • Is Mirum Pharmaceuticals Profitable?

    Mirum Pharmaceuticals reported $76.6M that represents $1.15 per share over the last quarter.

  • What is the Analyst Consensus for Mirum Pharmaceuticals EPS Next Year?

    Mirum Pharmaceuticals's earnings are forecast to decrease from -$1.85 per share to -$1.42 per share next year representing a decrease of -54.46%.

  • When is Mirum Pharmaceuticals's Earnings Date?

    Mirum Pharmaceuticals's next earnings date is May 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will MSTY Go By 2030?
How High Will MSTY Go By 2030?

YieldMax’s MSTR Option Income Strategy ETF (MSTY) is a high-yield…

Will NVIDIA Stock Bounce Back?
Will NVIDIA Stock Bounce Back?

After the wild market moves during February and March, investors…

Is Energy Transfer a Good Dividend Stock to Buy Now?
Is Energy Transfer a Good Dividend Stock to Buy Now?

Energy Transfer (NYSE:ET) offers an impressive yield, to say the…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 38x

Alerts

Sell
45
YPF alert for Apr 16

YPF SA [YPF] is down 3.95% over the past day.

Sell
42
RGC alert for Apr 16

Regencell Bioscience Holdings [RGC] is down 1.04% over the past day.

Sell
45
DSDVY alert for Apr 16

DSV AS [DSDVY] is up 9.6% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock